Get Instant Summarized Text (Gist) Elevated C-reactive protein, an inflammation marker, is associated with reduced activity in brain circuits related to reward and motivation in schizophrenia ...

The DSM-5 no longer recognizes schizophrenia subtypes as separate diagnostic categories. However, the five classical subtypes (paranoid, hebephrenic, undifferentiated, residual, and catatonic ...

Schizophrenia is a mental health condition that demands vigilance. Even with a good response to initial treatment, schizophrenia symptoms often return. A return or worsening of symptoms following ...

Get Instant Summarized Text (Gist) Newborns with vitamin D deficiency show an increased risk of developing schizophrenia, autism spectrum disorder, and ADHD later in life. Analysis of over 71,000 ...

Newborn babies with a vitamin D deficiency have a higher chance of later developing mental disorders such as ADHD, schizophrenia and autism, a major study involving The University of Queensland ...

Research in psychotic conditions increasingly focuses on improving functional outcomes. While antipsychotic treatments can alleviate positive symptoms in some patients, they have limited impact on ...

A young woman with nervous breakdown expressions on background. [Courtesy/iStock] Schizophrenia is one of the most misunderstood mental health disorders in our communities. Often dismissed as ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

In experiments involving mice, the team found that JRT improved negative symptoms of schizophrenia without worsening other behaviors associated with psychosis. While it's still far too early to ...

That is often the case when it comes to schizophrenia, a mental health condition that can cause symptoms of psychosis like hallucinations and delusions, as well as disruptions in thought processes.

A new study has suggested newborns who are vitamin D deficient at birth may be at a higher risk of some mental health disorders. Researchers analysed vitamin D levels from more than 70,000 people ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...